CVS Health Co. (NYSE:CVS) Shares Sold by UMB Bank n.a.

UMB Bank n.a. lessened its holdings in CVS Health Co. (NYSE:CVS) by 18.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,107 shares of the pharmacy operator’s stock after selling 3,507 shares during the quarter. UMB Bank n.a.’s holdings in CVS Health were worth $678,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new position in CVS Health in the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health during the third quarter valued at approximately $31,000. Reston Wealth Management LLC bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the 3rd quarter valued at approximately $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $53.14 on Wednesday. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The stock has a market capitalization of $66.87 billion, a P/E ratio of 13.49, a P/E/G ratio of 0.79 and a beta of 0.59. The firm’s 50 day moving average is $51.27 and its 200-day moving average is $56.29. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 earnings per share. Equities research analysts anticipate that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 5.01%. CVS Health’s dividend payout ratio is currently 67.51%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CVS. TD Cowen raised their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Barclays reduced their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Piper Sandler dropped their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.